BACKGROUND: Pontine tumors carry the worst prognosis of all brain tumors. In most cases, the diagnosis is based solely on MR imaging, without biopsy. OBJECTIVE: To describe the MR findings of pontine tumors at diagnosis and during follow-up and correlate those with prognosis and to assess the value of MR imaging in patient management compared to clinical evaluation. MATERIALS AND METHODS: Ninety-one MR scans of 15 children with diffuse pontine tumors were reviewed at diagnosis and during follow-up. The parameters analyzed were as follows: tumor extent, area, and volume; encasement of the basilar artery; presence of exophytic component; necrosis; cysts; hydrocephalus; and intensity and enhancement. Findings were correlated to length of progression-free and overall survival. Trends of amelioration or worsening on imaging were compared with the clinical findings. RESULTS: Median length of progression-free survival was 10 months, and median survival was 20 months. Only hydrocephalus at presentation was associated with shorter progression-free survival (P=0.02). On the last examination of each patient, the craniocaudal diameter was significantly greater than at diagnosis (P=0.03). The concordance between the imaging and the clinical findings was good. CONCLUSION: MR is the mainstay for the diagnosis and management of pontine tumors. Cranial growth seems to be an ominous sign. However, the prognostic value of MR is limited. MR findings correlate well with the clinical examination.
BACKGROUND:Pontine tumors carry the worst prognosis of all brain tumors. In most cases, the diagnosis is based solely on MR imaging, without biopsy. OBJECTIVE: To describe the MR findings of pontine tumors at diagnosis and during follow-up and correlate those with prognosis and to assess the value of MR imaging in patient management compared to clinical evaluation. MATERIALS AND METHODS: Ninety-one MR scans of 15 children with diffuse pontine tumors were reviewed at diagnosis and during follow-up. The parameters analyzed were as follows: tumor extent, area, and volume; encasement of the basilar artery; presence of exophytic component; necrosis; cysts; hydrocephalus; and intensity and enhancement. Findings were correlated to length of progression-free and overall survival. Trends of amelioration or worsening on imaging were compared with the clinical findings. RESULTS: Median length of progression-free survival was 10 months, and median survival was 20 months. Only hydrocephalus at presentation was associated with shorter progression-free survival (P=0.02). On the last examination of each patient, the craniocaudal diameter was significantly greater than at diagnosis (P=0.03). The concordance between the imaging and the clinical findings was good. CONCLUSION: MR is the mainstay for the diagnosis and management of pontine tumors. Cranial growth seems to be an ominous sign. However, the prognostic value of MR is limited. MR findings correlate well with the clinical examination.
Authors: M Benesch; H Lackner; A Moser; R Kerbl; W Schwinger; R Oberbauer; H G Eder; R Mayer; K Wiegele; C Urban Journal: Pediatr Neurosurg Date: 2001-10 Impact factor: 1.162
Authors: D Zagzag; D C Miller; E Knopp; J P Farmer; M Lee; S Biria; A Pellicer; F J Epstein; J C Allen Journal: Pediatrics Date: 2000-11 Impact factor: 7.124
Authors: P G Fisher; S N Breiter; B S Carson; M D Wharam; J A Williams; J D Weingart; D R Foer; P T Goldthwaite; T Tihan; P C Burger Journal: Cancer Date: 2000-10-01 Impact factor: 6.860
Authors: Z A Khatib; R L Heideman; E H Kovnar; J A Langston; R A Sanford; E C Douglas; J Ochs; J J Jenkins; D L Fairclough; C Greenwald Journal: Pediatr Neurosurg Date: 1994 Impact factor: 1.162
Authors: Emilie A Steffen-Smith; Eva H Baker; David Venzon; Shaefali Shandilya; Robyn S Bent; Katherine E Warren Journal: J Neurooncol Date: 2013-10-10 Impact factor: 4.130
Authors: James L Leach; James Roebker; Austin Schafer; Joshua Baugh; Brooklyn Chaney; Christine Fuller; Maryam Fouladi; Adam Lane; Renee Doughman; Rachid Drissi; Mariko DeWire-Schottmiller; David S Ziegler; Jane E Minturn; Jordan R Hansford; Stacie S Wang; Michelle Monje-Deisseroth; Paul G Fisher; Nicholas G Gottardo; Hetal Dholaria; Roger Packer; Katherine Warren; Sarah E S Leary; Stewart Goldman; Ute Bartels; Cynthia Hawkins; Blaise V Jones Journal: Neuro Oncol Date: 2020-11-26 Impact factor: 12.300
Authors: Stephen Harward; S Harrison Farber; Michael Malinzak; Oren Becher; Eric M Thompson Journal: Childs Nerv Syst Date: 2017-11-18 Impact factor: 1.475
Authors: Emilie A Steffen-Smith; Joelle E Sarlls; Carlo Pierpaoli; Joanna H Shih; Robyn S Bent; Lindsay Walker; Katherine E Warren Journal: Biomed Res Int Date: 2014-06-11 Impact factor: 3.411